NL130136C - - Google Patents

Info

Publication number
NL130136C
NL130136C NL130136DA NL130136C NL 130136 C NL130136 C NL 130136C NL 130136D A NL130136D A NL 130136DA NL 130136 C NL130136 C NL 130136C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL130136C publication Critical patent/NL130136C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL130136D 1966-10-20 NL130136C (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0089473 1966-10-20

Publications (1)

Publication Number Publication Date
NL130136C true NL130136C (ja)

Family

ID=6984787

Family Applications (2)

Application Number Title Priority Date Filing Date
NL130136D NL130136C (ja) 1966-10-20
NL6714189A NL6714189A (ja) 1966-10-20 1967-10-19

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6714189A NL6714189A (ja) 1966-10-20 1967-10-19

Country Status (8)

Country Link
US (1) US3471472A (ja)
AT (3) AT274252B (ja)
CH (1) CH491932A (ja)
DE (1) DE1670159A1 (ja)
FR (2) FR1552957A (ja)
GB (1) GB1139160A (ja)
NL (2) NL6714189A (ja)
SE (1) SE316775B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706728A (en) * 1969-03-19 1972-12-19 Boehringer Mannheim Gmbh N(6)-branched chain lower-alkyl-adenosine derivatives
US3887706A (en) * 1969-12-12 1975-06-03 Schering Ag N6-(3-Chlorobuten-2-yl)-adenosines as anti-inflammatory agents
JPS497414A (ja) * 1972-05-24 1974-01-23
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
JPH0631307B2 (ja) * 1985-04-27 1994-04-27 三共株式会社 グリゼオ−ル酸誘導体の製法
US4693996A (en) * 1985-12-23 1987-09-15 Warner-Lambert Company Method of treating heart failure and medicaments therefor
JPH0723394B2 (ja) * 1986-11-27 1995-03-15 日本臓器製薬株式会社 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
FR2663936A1 (fr) * 1987-12-23 1992-01-03 Glaxo Group Ltd Derives de l'adenosine, leur procede de preparation et leur utilisation en therapeutique.
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
WO1994002497A1 (en) * 1992-07-15 1994-02-03 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sulfo-derivatives of adenosine
JP2013513551A (ja) * 2009-12-10 2013-04-22 中国医学科学院葯物研究所 Ｎ６−置換アデノシン誘導体とｎ６−置換アデニン誘導体の鎮静、催眠，抗うつ，抗痙攣，抗てんかん，抗パーキンソン病と認知証予防・治療の用途
FR3053114B1 (fr) 2016-06-24 2018-07-27 Bruno Morel-Fatio Systeme numerique de mesure optique absolue d'un niveau de liquide dans un conteneur par correlation de prises de vues

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014900A (en) * 1959-01-26 1961-12-26 Upjohn Co Process for the preparation of ketosidopurines
US3225029A (en) * 1962-03-08 1965-12-21 Yamaoka Naotaka Process for the preparation of nucleosides and products obtained thereby
US3201389A (en) * 1962-09-24 1965-08-17 Kyowa Hakko Kogyo Kk Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides

Also Published As

Publication number Publication date
FR1552957A (ja) 1969-01-10
US3471472A (en) 1969-10-07
CH491932A (de) 1970-06-15
SE316775B (ja) 1969-11-03
GB1139160A (en) 1969-01-08
FR7270M (ja) 1969-09-15
DE1670159A1 (de) 1970-11-05
AT274252B (de) 1969-09-10
NL6714189A (ja) 1968-04-22
AT271739B (de) 1969-06-10
AT274251B (de) 1969-09-10

Similar Documents

Publication Publication Date Title
FR7270M (ja)
AT281852B (ja)
AU5917865A (ja)
AU428063B2 (ja)
AU1141566A (ja)
AU414526B2 (ja)
AU421822B2 (ja)
AU433222B2 (ja)
AU417216B2 (ja)
AU415165B1 (ja)
AU5895065A (ja)
AU1111066A (ja)
AU612166A (ja)
AU1144366A (ja)
AU218666A (ja)
AU411645B2 (ja)
BE677524A (ja)
BE692284A (ja)
BE692025A (ja)
BE693868A (ja)
AU2390066A (ja)
BE694113A (ja)
AU407778B2 (ja)
BE694540A (ja)
AU1027866A (ja)